Scribe Therapeutics, Inc. (SCTX): who owns it and who trades it
As of Nov 16, 2026, SCTX insiders reported 7 purchases worth $56.3M in the last 12 months. The largest buyer was Avoro Ventures LLC (Director), with $36.3M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Scribe Therapeutics
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, SCTX insiders reported $56.3M of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Avoro Ventures LLC +2 | Director | Purchase | 7,905 | $18.25 | $144K | Form 4 |
| Jul 27, 2026 | AH Equity Partners Bio II, L.L.C. +5 | 10% owner | Purchase | 333,333 | $15.00 | $5M | Form 4 |
| Jul 27, 2026 | Carl L Gordon | Director | Purchase | 1.00M | $15.00 | $15M | Form 4 |
| Jul 24, 2026 | Avoro Ventures LLC +2 | Director | Purchase | 50,000 | $22.31 | $1.1M | Form 4 |
| Jul 24, 2026 | Avoro Ventures LLC +2 | Director | Purchase | 2.33M | $15.00 | $35M | Form 4 |
| Jul 23, 2026 | Svetlana Lucas | Chief Business Officer | Purchase | 3,000 | $15.00 | $45K | Form 4 |
| Jul 23, 2026 | David Parrot | CFO | Purchase | 1,333 | $15.00 | $20K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Avoro Ventures LLC | Director | $36.3M | – | Jul 28, 2026 |
| Carl L Gordon | Director | $15M | – | Jul 27, 2026 |
| AH Equity Partners Bio II, L.L.C. | 10% owner | $5M | – | Jul 27, 2026 |
| Svetlana Lucas | Chief Business Officer | $45K | – | Jul 23, 2026 |
| David Parrot | Chief Financial Officer | $20K | – | Jul 23, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
SCTX short interest
Moderate short interest. 8.8% of SCTX shares are sold short: about 1 share in 11. Over the last 7 reports the number of shares short went up 535%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.67M SCTX shares were sold short, 8.8% of the shares outstanding, up 49.5% from the report before. At the average daily volume of 417,041 shares, buying them all back would take about 4.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.67M | 8.83% | +49% | 417,041 | 4.0 |
| Oct 15, 2026 | 1.12M | 5.91% | -55% | 474,424 | 2.4 |
| Sep 30, 2026 | 2.47M | 13.03% | +212% | 689,637 | 3.6 |
| Sep 15, 2026 | 790,538 | 4.18% | +2% | 173,433 | 4.6 |
| Aug 31, 2026 | 778,191 | 4.11% | +173% | 295,438 | 2.6 |
| Aug 14, 2026 | 284,711 | – | +8% | 132,875 | 2.1 |
| Jul 31, 2026 | 263,070 | – | – | 195,886 | 1.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Scribe Therapeutics company events
Scribe Therapeutics filed 2 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Sep 2, 2026.
- Sep 2, 2026ResultsReleased financial results. Filing
- Jul 27, 2026RulesChanged its bylaws or articles. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Famous investors that hold SCTX
2 of the 50 well-known investors we track reported holding SCTX in their latest 13F filing. The largest position is Cathie Wood's, worth $14.5M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Cathie Wood · ARK Investment Management | Q3 2026 | 786,921 | $14.5M | 0.1% | New |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 22,771 | $419K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named SCTX in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | AH Bio Fund II, L.P. | 13G | 12.6% |
| Nov 16, 2026 | AH Bio Fund II, L.P. | 13G | 12.6% |
Questions about Scribe Therapeutics, Inc. (SCTX) stock
Are SCTX insiders buying or selling?
In the last 12 months, SCTX insiders reported 7 open-market purchases worth $56.3M and no sales. The latest trade was on Jul 28, 2026. See every trade.
What is the short interest in SCTX?
As of Oct 30, 2026, 1.67M SCTX shares were sold short, 8.8% of the shares outstanding, up 49.5% from the report before. At the average daily volume of 417,041 shares, buying them all back would take about 4.0 trading days (days to cover). See the history.
Which famous investors hold SCTX?
2 of the 50 well-known investors we track reported SCTX in their latest 13F filing, including Cathie Wood, Steve Cohen. The largest position is worth $14.5M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.